Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


International Clinical Trial: Option 4 Antibacterial Effect of Moringa Mouthwash in Children With Mixed Dentition Wearing Orthodontic Appliances

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536438) titled 'Option 4 Antibacterial Effect of Moringa Mouthwash in Children With Mixed Den... Read More


International Clinical Trial: Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536490) titled 'Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease' on Apr... Read More


International Clinical Trial: Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536542) titled 'Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Dise... Read More


International Clinical Trial: Abdominal and Lower Extremity Adipose Tissue Elasticity in Patients With Lipedema

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536646) titled 'Abdominal and Lower Extremity Adipose Tissue Elasticity in Patients With Lipe... Read More


International Clinical Trial: VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536100) titled 'VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Andro... Read More